BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30797486)

  • 21. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
    Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
    Clin Lung Cancer; 2016 Sep; 17(5):e57-e64. PubMed ID: 27137345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma--analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules.
    Boland JM; Froemming AT; Wampfler JA; Maldonado F; Peikert T; Hyland C; de Andrade M; Aubry MC; Yang P; Yi ES
    Hum Pathol; 2016 May; 51():41-50. PubMed ID: 27067781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT features and quantitative analysis of subsolid nodule lung adenocarcinoma for pathological classification prediction.
    Li X; Zhang W; Yu Y; Zhang G; Zhou L; Wu Z; Liu B
    BMC Cancer; 2020 Jan; 20(1):60. PubMed ID: 31992239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma.
    Cao Y; Xu H; Liao M; Qu Y; Xu L; Zhu D; Wang B; Tian S
    Int J Clin Oncol; 2018 Apr; 23(2):249-257. PubMed ID: 28988295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Study of Surgical Treated Lung Adenocarcinoma with Ground Glass Nodule Component.
    Xu Y; Zheng M; Wang N; Wang R
    Med Sci Monit; 2019 Nov; 25():8492-8498. PubMed ID: 31710020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Pathologic Tumor Invasion and Prognosis for Ground Glass Opacity Featured Lung Adenocarcinoma.
    Ye T; Deng L; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Wang S; Xie L; Chen H
    Ann Thorac Surg; 2018 Dec; 106(6):1682-1690. PubMed ID: 30096292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiopathologic correlation of collision lung cancer with ground-glass opacity.
    Uchida S; Tsuta K; Kusumoto M; Shiraishi K; Kohno T; Watanabe SI
    Asian Cardiovasc Thorac Ann; 2019 Jan; 27(1):45-48. PubMed ID: 30417682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thin-section computed tomography-histopathologic comparisons of pulmonary focal interstitial fibrosis, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma with pure ground-glass opacity.
    Si MJ; Tao XF; Du GY; Cai LL; Han HX; Liang XZ; Zhao JM
    Eur J Radiol; 2016 Oct; 85(10):1708-1715. PubMed ID: 27666606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histogram analysis combined with morphological characteristics to discriminate adenocarcinoma in situ or minimally invasive adenocarcinoma from invasive adenocarcinoma appearing as pure ground-glass nodule.
    Zhang T; Pu XH; Yuan M; Zhong Y; Li H; Wu JF; Yu TF
    Eur J Radiol; 2019 Apr; 113():238-244. PubMed ID: 30927953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?
    Aherne EA; Plodkowski AJ; Montecalvo J; Hayan S; Zheng J; Capanu M; Adusumilli PS; Travis WD; Ginsberg MS
    Lung Cancer; 2018 Apr; 118():83-89. PubMed ID: 29572008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring ≤10 mm on thin-section computed tomography.
    Xiang W; Xing Y; Jiang S; Chen G; Mao H; Labh K; Jia X; Sun X
    Cancer Imaging; 2014 Nov; 14(1):33. PubMed ID: 25608623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marginal radiomics features as imaging biomarkers for pathological invasion in lung adenocarcinoma.
    Cho HH; Lee G; Lee HY; Park H
    Eur Radiol; 2020 May; 30(5):2984-2994. PubMed ID: 31965255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
    Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
    J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications.
    Ito M; Miyata Y; Kushitani K; Yoshiya T; Mimae T; Ibuki Y; Misumi K; Takeshima Y; Okada M
    Lung Cancer; 2014 Aug; 85(2):270-5. PubMed ID: 24976332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-depth proteomics reveals the characteristic developmental profiles of early lung adenocarcinoma with epidermal growth factor receptor mutation.
    Dai T; Adachi J; Dai Y; Nakano N; Yamato M; Kikuchi S; Usui S; Minami Y; Tomonaga T; Noguchi M; Matsubara D; Sakamoto N
    Cancer Med; 2023 May; 12(9):10755-10767. PubMed ID: 37004157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminating between bronchiolar adenoma, adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung with CT.
    Cao L; Wang Z; Gong T; Wang J; Liu J; Jin L; Yuan Q
    Diagn Interv Imaging; 2020 Dec; 101(12):831-837. PubMed ID: 32482582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinoma.
    Ito M; Miyata Y; Kushitani K; Yoshiya T; Kai Y; Tsutani Y; Mimura T; Konishi K; Takeshima Y; Okada M
    Thorac Cancer; 2018 Dec; 9(12):1594-1602. PubMed ID: 30298562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Air bronchogram: A potential indicator of epidermal growth factor receptor mutation in pulmonary subsolid nodules.
    Dai J; Shi J; Soodeen-Lalloo AK; Zhang P; Yang Y; Wu C; Jiang S; Jia X; Fei K; Jiang G
    Lung Cancer; 2016 Aug; 98():22-28. PubMed ID: 27393502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
    Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
    Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CT findings of minimally invasive adenocarcinoma (MIA) of the lung and comparison of solid portion measurement methods at CT in 52 patients.
    Lee SM; Goo JM; Lee KH; Chung DH; Koh J; Park CM
    Eur Radiol; 2015 Aug; 25(8):2318-25. PubMed ID: 25680719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.